Bakker estimates that hundreds of compounds left on big pharma’s shelves could become much-needed drugs, but she acknowledges ...

The tariff is a reduction from the 25% levy that US president Donald J. Trump had threatened to impose on Japan if the ...

Fluorescent nanoparticles used to image a tumor near a mouse’s hind legs (circled, left) can accumulate in off-target organs, ...

AstraZeneca has elected not to move forward with a COVID-19 preventive in the US, despite approvals in other parts of the ...

Eastman to recast plastics recycling plant, Bayer to launch new herbicide, Trump pressures drug companies to reduce prices, ...

Companies that broker and facilitate scientific fraud are large, resilient, and growing rapidly, according to a new study.

The journal cites experimental error as the reason for the decision, which comes nearly 15 years after the paper’s ...

After years of discussions, 107 nations agree to establish the Intergovernmental Science-Policy Panel on Chemicals, Waste and Pollution ...

We may be on the cusp of a new era of biochemical discovery, but turning these advancements into drugs isn’t so easy ...

As the world gets wetter, studying a water cycle in flux is a major challenge. ‘You cannot bring a cloud into a laboratory,’ ...

F or a chemistry undergraduate focused on synthesis, pivoting to a PhD in physics is a bold move. But that’s exactly what Sascha Feldmann did—unlocking a research career that fuses materials ...